« Previous Next » JACC: Cardiovascular Imaging
Volume 2, Issue 2 , Pages 187-198 , February 2009

Molecular Imaging for Efficacy of Pharmacologic Intervention in Myocardial Remodeling

Susanne W.M. van den Borne, MD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
Satoshi Isobe, MD, PhD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
H. Reinier Zandbergen, MD
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
Peng Li, MD, PhD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Artiom Petrov, PhD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Nathan D. Wong, PhD, FACC
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Shinichiro Fujimoto, MD, PhD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Ai Fujimoto, MD, PhD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Dagfinn Lovhaug, PhD
- GE Healthcare, AS, Oslo, Norway
Jos F.M. Smits, PhD
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
Mat J.A.P. Daemen, MD, PhD
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
W. Matthijs Blankesteijn, PhD
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
Chris Reutelingsperger, PhD
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
Faiez Zannad, MD, PhD, FACC
- University Henri Poincaré, Nancy, France
Navneet Narula, MD
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Mani A. Vannan, MD, FACC
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
Bertram Pitt, MD, FACC
- Division of Cardiology, University of Michigan, Ann Arbor, Michigan
Leonard Hofstra, MD, PhD
- Department of Cardiology, Biochemistry, Pathology and Pharmacology, University Hospital Maastricht, Maastricht, the Netherlands
Jagat Narula, MD, PhD, FACC
- Division of Cardiology and Department of Pathology, University of California, Irvine School of Medicine, Irvine, California
- Reprint requests and correspondence: Dr. Jagat Narula, Division of Cardiology, University of California, Irvine School of Medicine, UCI Main Campus, Medical-Science Building I, Room C 112, Irvine, California 92697

Received 9 June 2008 ,Revised 31 October 2008 ,Accepted 6 November 2008.

To access this article, please choose from the options below

Dr. van den Borne was partially supported by a grant from the Netherlands Heart Foundation (2006R013). Dr. Lovhaug is an employee of GE Healthcare, involved in tracer preparation for the imaging studies. Dr. Pitt is a consultant to Pfizer, Merck, Takeda, Astra Zeneca, Synvista, Novartis, and Nile therapeutics but has no conflicts directly with the project. H. William Strauss, MD, acted as Guest Editor for this paper.

PII: S1936-878X(08)00517-2

doi: 10.1016/j.jcmg.2008.11.011

« Previous Next » JACC: Cardiovascular Imaging
Volume 2, Issue 2 , Pages 187-198 , February 2009